TCM evidence-based capacity building and evidence-based implementation plan of TCM combined with chemotherapy in treatment of metastatic colorectal cancer:A bidirectional cohort study of Zhenqiliujun anti-cancer granules combined with mFOLFOX6/FOLFIRI regimen and bevacizumab/cetuximab in first-line treatment of advanced metastatic colorectal

ABSTRACT: Interventions: TCM combined with chemotherapy:MFOLFOX6 /FOLFIRI regimen + bevacizumab/cetuximab + Zhenqi Liujun cancer suppressant granules.;Chemotherapy group:MFOLFOX6 /FOLFIRI + bevacizumab/cetuximab Primary outcome(s): Progression-free survival;Adverse incident Study Design: Non randomized control

DISEASE(S): Colorectal Cancer

PROVIDER: 2705538 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR